Research Update: LMNA
We are honored to support groundbreaking discoveries related to LMNA-CMD.
top of page
Search
Gustavo Dziewczapolski, Scientific Director
Aug 73 min read
Research Update: Dystroglycanopathy
We are honored to support groundbreaking discoveries related to Dystroglycanopathy.
Gustavo Dziewczapolski, Scientific Director
Jul 24 min read
Research Update: LAMA2
We are honored to support groundbreaking discoveries related to LAMA2-Related Dystrophy.
Gustavo Dziewczapolski, Scientific Director
Jun 62 min read
iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies
The MAGIC research team welcomes iMM to the consortium to add a cellular perspective to muscle-on-chip technologies
Rachel Alvarez
Jun 52 min read
Omigapil Publication Now Available
Long-awaited publication about the Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy now published.
Gustavo Dziewczapolski, Scientific Director
May 284 min read
Research Update: SELENON
We are honored to support groundbreaking discoveries related to SELENON-Related Disorders.
Gustavo Dziewczapolski, Scientific Director
May 12 min read
2024 Myology Congress Recap
Cure CMD’s Scientific Director, Dr. Gustavo Dziewczapolski, provides a recap of his attendance at the 8th International Myology Congress in
Gustavo Dziewczapolski, Scientific Director
Apr 164 min read
Research Update: Collagen 6
We are honored to support groundbreaking discoveries in Collagen 6-Related Dystrophies (COL6-RD).
Cure CMD
Sep 29, 20232 min read
An Exciting Milestone for LAMA2-CMD
Expanding on nearly a decade of partnership in the life sciences, the Translational Sciences team at UPMC Enterprises and the University...
bottom of page